Kelyniam Global, Inc. (KLYG)

0.0430 0.0000 (0.00%) At close: 02:41PM EDT

Kelyniam Global, Inc.

97 River Road
Suite A
Collinsville, CT 06019
United States
800 280 8192
https://www.kelyniam.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Ross Bjella	Chairman & CEO	N/A	N/A	1962
Mr. Terrance Kurtenbach	Chief Financial Officer	N/A	N/A	N/A
Michael Hamblett	Director of Investor Relations	N/A	N/A	N/A
Mr. James Barrow Esq.	General Counsel and Director of Quality & Regulatory	N/A	N/A	N/A
Dr. Mark V. Smith M.D.	VP of Sales & Business Development and Director	N/A	N/A	N/A
Dr. Christopher Mirucki	Chief Medical Officer	N/A	N/A	N/A

Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Kelyniam Global, Inc., a medical device manufacturing company, engages in the production of custom prosthetics cranial implants utilizing computer aided design, and computer aided manufacturing of advanced medical grade polymers in the United States. The company is also involved in the development, manufacture, and distribution of custom cranial and maxilla-facial implant for patients requiring the reconstruction of cranial and facial structures. It serves surgeons, health systems, and payors. The company was formerly known as Ketner Global Investments, Inc. and changed its name to Kelyniam Global, Inc. in December 2007. Kelyniam Global, Inc. was incorporated in 2005 and is based in Collinsville, Connecticut.

Corporate Governance

Kelyniam Global, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.